Related Experiment Videos
Evolution of drug resistance in Candida albicans
Leah E Cowen1, James B Anderson, Linda M Kohn
1Department of Botany, University of Toronto, Mississauga, Ontario, L5L 1C6, Canada. lcowen@utm.utoronto.ca
Abstract:
The widespread deployment of antimicrobial agents in medicine and agriculture is nearly always followed by the evolution of resistance to these agents in the pathogen. With the limited availability of antifungal drugs and the increasing incidence of opportunistic fungal infections, the emergence of drug resistance in fungal pathogens poses a serious public health concern. Antifungal drug resistance has been studied most extensively with the yeast Candida albicans owing to its importance as an opportunistic pathogen and its experimental tractability relative to other medically important fungal pathogens. The emergence of antifungal drug resistance is an evolutionary process that proceeds on temporal, spatial, and genomic scales. This process can be observed through epidemiological studies of patients and through population-genetic studies of pathogen populations. Population-genetic studies rely on sampling of the pathogen in patient populations, serial isolations of the pathogen from individual patients, or experimental evolution of the pathogen in nutrient media or in animal models. Predicting the evolution of drug resistance is fundamental to prolonging the efficacy of existing drugs and to strategically developing and deploying novel drugs.
Insights
Antifungal drug resistance in pathogens like Candida albicans is a growing public health threat. Understanding its evolutionary process is key to developing new antifungal drugs and preserving existing ones.
Area of Science:
- Microbiology
- Evolutionary Biology
- Public Health
Background:
- Antimicrobial agent deployment drives pathogen resistance.
- Increasing opportunistic fungal infections and limited antifungal drugs create a public health concern.
- Candida albicans is a key model organism for studying antifungal drug resistance.
Purpose of the Study:
- To investigate the evolutionary process of antifungal drug resistance.
- To understand the temporal, spatial, and genomic scales of resistance emergence.
- To inform strategies for prolonging drug efficacy and developing new antifungal therapies.
Main Methods:
- Epidemiological studies of patient data.
- Population-genetic studies of pathogen populations.
- Experimental evolution in nutrient media and animal models.
Main Results:
- Antifungal drug resistance emerges through an evolutionary process.
- Resistance evolution occurs across temporal, spatial, and genomic dimensions.
- Studies on Candida albicans provide insights into resistance mechanisms.
Conclusions:
- Predicting antifungal drug resistance evolution is crucial for effective treatment strategies.
- Understanding evolutionary dynamics aids in the development and deployment of novel antifungal drugs.
- Continued research on Candida albicans and other fungal pathogens is essential to combat resistance.